Table 2.
Global strain and indexed global strain values measured at different inotropic states
| Baseline | Dobutamine | Verapamil | |
|---|---|---|---|
| (A) | |||
| GLS (%) | − 23 ± 4 | − 45 ± 9* | − 16 ± 3*,§ |
| GCS (%) | − 31 ± 8 | − 53 ± 10* | − 17 ± 5*,§ |
| GRS (%) | 72 ± 19 | 88 ± 36 | 30 ± 12*,§ |
| (B) | |||
| GLSi (%) | − 23 ± 4 | − 45 ± 10* | − 16 ± 4*,§ |
| GCSi (%) | − 30 ± 8 | − 52 ± 8* | − 16 ± 5*,§ |
| GRSi (%) | 71 ± 19 | 84 ± 23 | 30 ± 13*,§ |
| (C) | |||
| GLSw (%) | − 23 ± 5 | − 44 ± 10* | − 16 ± 3*,§ |
| GCSw (%) | − 31 ± 9 | − 52 ± 13* | − 17 ± 17*,§ |
| GRSw (%) | 71 ± 20 | 90 ± 54 | 35 ± 27*,§ |
(A) Global strain: GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain; (B) Global strain indexed for mean aortic pressure (mAoP): GLSi global longitudinal strain indexed for mAoP, GCSi global circumferential strain indexed for mAOP, GRSi global radial strain indexed for mAoP; (C) Global strain indexed for meridional wall stress: GLSw global longitudinal strain indexed for wall stress, GCSw global circumferential strain indexed for wall stress, GRSw global radial strain indexed for wall stress. *p < 0.05 vs. baseline; §p < 0.05 vs. Dobutamine